Anika is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. We partner with clinicians to understand what they need most to treat their patients and we develop minimally invasive products that restore active living for people around the world. We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies.
Our passionate team partners with clinicians to create and deliver significant advances in early intervention orthopedic care. We are resolute in our commitment to quality and compliance as we develop and commercialize solutions that restore the active lives of people around the world.
With over 30 years of global expertise developing, manufacturing and commercializing products based on hyaluronic acid (HA), a naturally occurring polymer found throughout the body and vital for proper joint health and tissue function, we are a leader in viscosupplement injectables for osteoarthritis (OA) pain management. Our proprietary technologies for modifying the HA molecule allow product properties to be specifically tailored for multiple uses, including enabling longer residence times to support OA pain management and creating a solid form of HA called HIAFF.
We have recently expanded our technology portfolio and commercial infrastructure in sports medicine and partial bone protection solutions. Thanks to less invasive technologies our patients have the ability to return to normal activity without having to undergo total joint replacement procedures. We are focused on restoring an active life.